InventionMed S.A. (WSE: INM)
Poland
· Delayed Price · Currency is PLN 0.207
+0.001 (0.24%)
At close: Jan 30, 2025
InventionMed Revenue
InventionMed had revenue of 115.76K PLN in the quarter ending September 30, 2024, with 38,486.67% growth. This brings the company's revenue in the last twelve months to 162.32K, up 26,729.75% year-over-year. In the year 2023, InventionMed had annual revenue of 605.00, down -85.12%.
Revenue (ttm)
162.32K
Revenue Growth
+26,729.75%
P/S Ratio
257.50
Revenue / Employee
40.58K
Employees
7
Market Cap
41.77M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 605.00 | -3.46K | -85.12% |
| Dec 31, 2022 | 4.07K | -6.39K | -61.10% |
| Dec 31, 2021 | 10.45K | 5.25K | 100.96% |
| Dec 31, 2020 | 5.20K | -35.80K | -87.32% |
| Dec 31, 2019 | 41.00K | - | - |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 12.34B |
| Synektik Spólka Akcyjna | 624.80M |
| Voxel | 492.41M |
| Celon Pharma | 209.54M |
| Selvita | 334.42M |
| Ryvu Therapeutics | 91.18M |
| Centrum Medyczne ENEL-MED | 680.32M |
| Mercator Medical | 488.78M |